Cholesterol excess

The final chapter in part 5, chapter 20, Metabolism of Cholesterol, deals with the synthesis of cholesterol and some of its derivatives, the steroid hormones and the bile acids. This chapter considers the structure, function and metabolism of these molecules. Also, the health-related concerns associated with cholesterol excess are addressed. 

Other lines of evidence also support the notion that deregulated cholesterol homeostasis may contribute to the AD pathogenesis. AD patients have been reported to develop intracellular A/1 accumulation in the late endo-somes and lysosomes. Similar pathological features, including swollen late endosomes and A/ accumulation, have also been reported in Niemann-Pick type C disease patients [52,53], Npcl deficient mice as well as in mouse models of AD [54,55]. The Npcl gene product is essential for the mobihzation of cellular cholesterol. Excess cholesterol can be transported into endoplasmic reticulum and esterified by acyl co enzyme A cholesterol acyltransferase (ACAT) and stored in lipid droplets. Inhibition of ACAT activity has been reported to reduce A/3 levels in vitro and plaque pathology in animal models of AD [56,57]. 

McFerrin J, Engel WK, Leclerc N et al. (2002) Combined influence of amyloid-beta precursor protein (AbPP) gene transfer and cholesterol excess on cultured humen muscle fibers. Neurology 58, 489. 

The regulatory implication of such a proposal is shown in Fig. 9. In the event of cholesterol excess, such as dietary cholesterol entering the cell, the regulatory adjustment would be as follows HMG-CoA reductase activity would decline, as a consequence of phosphorylation, whereas the activities of AC AT and 7 a-hydroxylase enzymes would be stimulated. In the instance of cholesterol deprivation, for example a cholesterol-free diet or a cultured liver cell grown in lipid-deficient medium, the regulatory adjustment would be HMG-CoA reductase activity would increase as a consequence of dephosphorylation, but AC AT and 7a-hydroxylase activities would decline under these conditions. 

Cholesterol is biosynthesized in the liver trans ported throughout the body to be used in a va riety of ways and returned to the liver where it serves as the biosynthetic precursor to other steroids But cholesterol is a lipid and isn t soluble in water How can it move through the blood if it doesn t dis solve in if The answer is that it doesn t dissolve but IS instead carried through the blood and tissues as part of a lipoprotein (lipid + protein = lipoprotein) The proteins that carry cholesterol from the liver are called low density lipoproteins or LDLs those that return it to the liver are the high-density lipoproteins or HDLs If too much cholesterol is being transported by LDL or too little by HDL the extra cholesterol builds up on the walls of the arteries caus mg atherosclerosis A thorough physical examination nowadays measures not only total cholesterol con centration but also the distribution between LDL and HDL cholesterol An elevated level of LDL cholesterol IS a risk factor for heart disease LDL cholesterol is bad cholesterol HDLs on the other hand remove excess cholesterol and are protective HDL cholesterol IS good cholesterol... 

Unfortunately, excess consumption of fatty foods has been correlated with serious human disease conditions. Effects on cardiovascular disease (95), cancer (96), and function of the immune system (97) have been shown. Numerous studies have been conducted to determine the effects of saturated, monounsaturated, and polyunsaturated fatty acids on semm cholesterol and more recently high density Hpoprotein (HDL) and low density Hpoprotein... 

Of the water-soluble vitamins, intakes of nicotinic acid [59-67-6] on the order of 10 to 30 times the recommended daily allowance (RE)A) have been shown to cause flushing, headache, nausea, and moderate lowering of semm cholesterol with concurrent increases in semm glucose. Toxic levels of foHc acid [59-30-3] are ca 20 mg/d in infants, and probably approach 400 mg/d in adults. The body seems able to tolerate very large intakes of ascorbic acid [50-81-7] (vitamin C) without iH effect, but levels in excess of 9 g/d have been reported to cause increases in urinary oxaHc acid excretion. Urinary and blood uric acid also rise as a result of high intakes of ascorbic acid, and these factors may increase the tendency for formation of kidney or bladder stones. AH other water-soluble vitamins possess an even wider margin of safety and present no practical problem (82). 

Dry chemistry tests are used for the assay of metaboHtes by concentration or by activity in a biological matrix. In general, reactive components are present in amounts in excess of the analyte being deterrnined to make sure that the reactions go to completion quickly. Other enzymes or reagents are used to drive the reactions in the desired direction (25). Glucose and cholesterol are the analytes most commonly measured. 

Despite stmctural similarities, the pharmacological consequences of excesses of these substances are quite different. Due to the interest in the effects of nicotinic acid on atherosclerosis, and in particular its use based on its abiUty to lower semm cholesterol, the toxicity of large doses of nicotinic acid has been evaluated. Eor example, in a study designed to assess its abiUty to lower semm cholesterol, only 28% of the patients remained in the study after receiving a large initial dose of 4 g of nicotinic acid due to intolerance at these large doses (70). 

Cholestanol, cholesterol Apply sample solution, treat with a 2 to 3-fold excess of 0.1% bromine in chloroform. Only cholesterol is derivatized. [45]... 

Dehydrated cholesterol Apply sample solution then place TLC plate in an iodine vapor chamber, blow off excess iodine. Di- and trimeric components are produced. [54]... 

Acid (69)." To a well-stirred mixture of 108 g (0.232 mole) of cholesterol acetate and 1.2 liters of glacial acetic acid is added over a period of 2 hr, a solution of 70 g of chromium trioxide in 200 ml of 50 % glacial acetic acid. The reaction mixture is maintained at a temperature of 55°. Upon completion of the addition, the mixture is stirred for an additional 2 hr at 55°. Excess chromic acid is destroyed by addition of 60 ml of methanol, and then 800 ml of acetic acid is removed by distillation under reduced pressure at a bath temperature of 40°. The remaining liquid is diluted with 50 ml of water and allowed to stand for 12 hr. The crystalline 7-ketocholesterol acetate which separates is removed by filtration and washed with 80 % acetic acid to yield 33.3 g (35%) of (68) mp 149-152°. 

Disorders of lipoprotein metabolism involve perturbations which cause elevation of triglycerides and/or cholesterol, reduction of HDL-C, or alteration of properties of lipoproteins, such as their size or composition. These perturbations can be genetic (primary) or occur as a result of other diseases, conditions, or drugs (secondary). Some of the most important secondary disorders include hypothyroidism, diabetes mellitus, renal disease, and alcohol use. Hypothyroidism causes elevated LDL-C levels due primarily to downregulation of the LDL receptor. Insulin-resistance and type 2 diabetes mellitus result in impaired capacity to catabolize chylomicrons and VLDL, as well as excess hepatic triglyceride and VLDL production. Chronic kidney disease, including but not limited to end-stage... 

PPARa Liver, heart, skeletal muscle, atherosclerotic lesions TG- and LDL-C-lowering and HDL-C-raising re-directs excess cholesterol from the peripheral tissues to the liver for excretion into the bile via HDL-C slowed progression of atherosclerosis Fatty acids, eico-sanoids (fatty acids derived from FAS ) Fibrates fenofibrate (Tricor ), genfibrozil (Lopid ) Dyslipidemia... 

Excessive secretion of gastric acid, associated with Helicobacter pylori infection, can result in the development of gastric and duodenal ulcers small changes in the composition of bile can result in crystallization of cholesterol as gallstones failure of exocrine pancreatic secretion (as in cystic fibrosis) leads to undernutrition... 

Most commonly, the lipid metabolism pathology is manifest as hyperlipemia (elevated concentration of lipids in blood) and tissue lipidoses (excessive lipid de-position in tissues). Normally, the lipid contents in the blood plasma are total lipids, 4-8 g/litre triglycerides, 0.5-2.1 mmol/litre total phospholipids, 2.0-3.5 mmol/litre total cholesterol, 4.0-8.0 mmol/litre (esterified cholesterol accounts for 2/3 of total cholesterol). 

It would be very interesting to go back into the other cohorts, in which no difference in cholesterol reduction between the genotypes has been seen and to examine, whether the statin treatment also abolished excess mortality of apo E4 carriers. 

---